0002099188 2026-03-31 2026-03-31 0002099188 SPEXU:InsiderSharesMember 2026-03-31 2026-03-31 0002099188 SPEXU:SponsorOfficersAndDirectorsMember 2026-03-31 2026-03-31 0002099188 SPEXU:InsiderSharesMember SPEXU:SpectreRHLimitedOfficersAndDirectorsMember 2026-03-31 2026-03-31 0002099188 SPEXU:PrivateUnitsMember SPEXU:SpectreRHLimitedOfficersAndDirectorsMember 2026-03-31 2026-03-31 0002099188 SPEXU:UnderwritersOverAllotmentOptionMember SPEXU:SpectreRHLimitedOfficersAndDirectorsMember 2026-03-31 2026-03-31 0002099188 SPEXU:PrivatePlacementWarrantsMember SPEXU:SpectreRHLimitedOfficersAndDirectorsMember 2026-03-31 2026-03-31 0002099188 SPEXU:LoanMember SPEXU:SpectreRHLimitedOfficersAndDirectorsMember 2026-03-31 2026-03-31 0002099188 spac:OverAllotmentOptionExercisedMember SPEXU:OfferingPriceOf10.00PerUnitMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionNotExercisedMember SPEXU:OfferingPriceOf10.00PerUnitMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:DifferenceBetweenNTBVAndOfferingPriceMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:DifferenceBetweenNTBVAndOfferingPriceMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:DifferenceBetweenNTBVAndOfferingPriceMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:DifferenceBetweenNTBVAndOfferingPriceMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:DifferenceBetweenNTBVAndOfferingPriceMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:DifferenceBetweenNTBVAndOfferingPriceMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:DifferenceBetweenNTBVAndOfferingPriceMember 2025-12-31 2025-12-31 0002099188 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:DifferenceBetweenNTBVAndOfferingPriceMember 2025-12-31 2025-12-31 0002099188 SPEXU:SpectreRHLimitedMember 2026-03-31 2026-03-31 0002099188 spac:NoRedemptionMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:RedemptionAt25PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:RedemptionAt50PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:RedemptionAt75PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:RedemptionAt100PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:NoRedemptionMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:RedemptionAt25PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:RedemptionAt50PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:RedemptionAt75PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:RedemptionAt100PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:NetProceedsFromThisOfferingAndTheSaleOfPrivateUnitsMember spac:NoRedemptionMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:NetProceedsFromThisOfferingAndTheSaleOfPrivateUnitsMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:NetProceedsFromThisOfferingAndTheSaleOfPrivateUnitsMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:NetProceedsFromThisOfferingAndTheSaleOfPrivateUnitsMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:NetProceedsFromThisOfferingAndTheSaleOfPrivateUnitsMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OfferingCostsAccruedForAndPaidInAdvanceExcludedFromTangibleBookValueMember spac:NoRedemptionMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OfferingCostsAccruedForAndPaidInAdvanceExcludedFromTangibleBookValueMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OfferingCostsAccruedForAndPaidInAdvanceExcludedFromTangibleBookValueMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OfferingCostsAccruedForAndPaidInAdvanceExcludedFromTangibleBookValueMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OfferingCostsAccruedForAndPaidInAdvanceExcludedFromTangibleBookValueMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:DeferredUnderwritingCommissionsMember spac:NoRedemptionMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:DeferredUnderwritingCommissionsMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:DeferredUnderwritingCommissionsMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:DeferredUnderwritingCommissionsMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:DeferredUnderwritingCommissionsMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:ProceedsSubjectToRedemptionMember spac:NoRedemptionMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:ProceedsSubjectToRedemptionMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:ProceedsSubjectToRedemptionMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:ProceedsSubjectToRedemptionMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:ProceedsSubjectToRedemptionMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:NoRedemptionMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPublicUnitsOfferedMember spac:NoRedemptionMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPublicUnitsOfferedMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPublicUnitsOfferedMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPublicUnitsOfferedMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPublicUnitsOfferedMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPrivateUnitsMember spac:NoRedemptionMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPrivateUnitsMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPrivateUnitsMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPrivateUnitsMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPrivateUnitsMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesSubjectToRedemptionMember spac:NoRedemptionMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesSubjectToRedemptionMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesSubjectToRedemptionMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesSubjectToRedemptionMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesSubjectToRedemptionMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:FullOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:NetProceedsFromThisOfferingAndTheSaleOfPrivateUnitsMember spac:NoRedemptionMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:NetProceedsFromThisOfferingAndTheSaleOfPrivateUnitsMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:NetProceedsFromThisOfferingAndTheSaleOfPrivateUnitsMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:NetProceedsFromThisOfferingAndTheSaleOfPrivateUnitsMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:NetProceedsFromThisOfferingAndTheSaleOfPrivateUnitsMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OfferingCostsAccruedForAndPaidInAdvanceExcludedFromTangibleBookValueMember spac:NoRedemptionMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OfferingCostsAccruedForAndPaidInAdvanceExcludedFromTangibleBookValueMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OfferingCostsAccruedForAndPaidInAdvanceExcludedFromTangibleBookValueMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OfferingCostsAccruedForAndPaidInAdvanceExcludedFromTangibleBookValueMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OfferingCostsAccruedForAndPaidInAdvanceExcludedFromTangibleBookValueMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:DeferredUnderwritingCommissionsMember spac:NoRedemptionMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:DeferredUnderwritingCommissionsMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:DeferredUnderwritingCommissionsMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:DeferredUnderwritingCommissionsMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:DeferredUnderwritingCommissionsMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:OverallotmentLiabilityMember spac:NoRedemptionMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:OverallotmentLiabilityMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:OverallotmentLiabilityMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:OverallotmentLiabilityMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 spac:OverallotmentLiabilityMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:ProceedsSubjectToRedemptionMember spac:NoRedemptionMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:ProceedsSubjectToRedemptionMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:ProceedsSubjectToRedemptionMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:ProceedsSubjectToRedemptionMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:ProceedsSubjectToRedemptionMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:NoRedemptionMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPublicUnitsOfferedMember spac:NoRedemptionMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPublicUnitsOfferedMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPublicUnitsOfferedMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPublicUnitsOfferedMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPublicUnitsOfferedMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPrivateUnitsMember spac:NoRedemptionMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPrivateUnitsMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPrivateUnitsMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPrivateUnitsMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesIncludedInPrivateUnitsMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesSubjectToRedemptionMember spac:NoRedemptionMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesSubjectToRedemptionMember spac:RedemptionAt25PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesSubjectToRedemptionMember spac:RedemptionAt50PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesSubjectToRedemptionMember spac:RedemptionAt75PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:OrdinarySharesSubjectToRedemptionMember spac:RedemptionAt100PercentOfMaximumMember SPEXU:NoOverAllotmentMember 2025-12-31 2025-12-31 0002099188 SPEXU:InsiderSharesMember 2026-03-31 2026-03-31 0002099188 SPEXU:PrivateUnitsMember 2026-03-31 2026-03-31 0002099188 spac:PublicUnitsMember 2026-03-31 2026-03-31 iso4217:USD pure iso4217:USD shares shares true 0002099188 S-1/A Amendment No. 1 Spectre Acquisition Corp E9 6770 Non-accelerated Filer true true false true true If we anticipate that we may not be able to consummate our initial business combination within 18 months from the closing of this initial public offering, subject to extension up to 21 months by means of three one-month extensions provided that $0.033 per public share is deposited into the trust account for each one-month extension and further provided that the Company has entered into an agreement for an initial business combination within that 18-month period, we may seek shareholder approval to extend the date by which we must consummate our initial business combination on terms to be specified in the relevant proxy solicitation statement. In the event an amendment to our amended and restated memorandum and articles of association is made (A) that would modify the substance or timing of our obligation to provide our public shareholders the right of redemption in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 18 months following the closing of this offering, subject to extension up to 21 months by means of three one-month extensions, or (B) with respect to any other provision of our amended and restated memorandum and articles of association relating to the rights of our public shareholders or pre-business combination activity, our amended and restated memorandum and articles of association also require us to provide our public shareholders who are not our sponsor, directors or officers with the opportunity to redeem their public shares upon the approval or effectiveness of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (net of taxes payable), divided by the number of then outstanding public shares, subject to the limitations described herein. P21M 1725000 25000 0.014 1730000 <p id="xdx_80C_espac--SpacOfferingForepartAdjustedNetTangibleBookValuePerShareTableTextBlock_dU_zqtJ1D8Ymjn3" style="font: 10pt Times New Roman,serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom"> <td colspan="34" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center">December 31, 2025</td> <td style="font-family: Times New Roman,serif"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1pt solid"> Offering Price of $10.00 and No Redemption</td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif"> </td> <td colspan="6" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center">25% of Maximum Redemption</td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif"> </td> <td colspan="6" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center">50% of Maximum Redemption</td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif"> </td> <td colspan="6" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center">75% of Maximum Redemption</td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif"> </td> <td colspan="6" style="border-bottom: black 1pt solid; font-family: Times New Roman,serif; text-align: center">100% of Maximum Redemption</td> <td style="font-family: Times New Roman,serif"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; font-family: Times New Roman,serif; text-align: center">NTBV</td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; font-family: Times New Roman,serif; text-align: center">NTBV</td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; font-family: Times New Roman,serif; text-align: center">Difference between NTBV and Offering Price</td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; font-family: Times New Roman,serif; text-align: center">NTBV</td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; font-family: Times New Roman,serif; text-align: center">Difference between NTBV and Offering Price</td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; font-family: Times New Roman,serif; text-align: center">NTBV</td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; font-family: Times New Roman,serif; text-align: center">Difference between NTBV and Offering Price</td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; font-family: Times New Roman,serif; text-align: center">NTBV</td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; font-family: Times New Roman,serif; text-align: center">Difference between NTBV and Offering Price</td> <td style="text-align: center; font-family: Times New Roman,serif; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="34" style="font-family: Times New Roman,serif; text-align: center">Assuming Full Exercise of Over-Allotment Option</td> <td style="font-family: Times New Roman,serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 1%; font-family: Times New Roman,serif">$</td> <td style="width: 16%; font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90D_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--SecurityClassAxis__custom--OfferingPriceOf10.00PerUnitMember_zEWAGYaRS3eg">7.79</td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif">$</td> <td style="width: 8%; font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_900_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_zu6weiMZudhc" style="font-size: 10pt">7.25</td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif">$</td> <td style="width: 8%; font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_90C_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember__spac--SecurityClassAxis__custom--DifferenceBetweenNTBVAndOfferingPriceMember_ztDpoNnzm4c3" style="font-size: 10pt">2.75</td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif">$</td> <td style="width: 7%; font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_900_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_zRdGvXuujcv6">6.38</td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif">$</td> <td style="width: 7%; font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_90B_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember__spac--SecurityClassAxis__custom--DifferenceBetweenNTBVAndOfferingPriceMember_zcSrE3is7Vsk">3.62</td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif">$</td> <td style="width: 7%; font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_908_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_zCWYGcVGzI43">4.69</td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif">$</td> <td style="width: 7%; font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_90F_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember__spac--SecurityClassAxis__custom--DifferenceBetweenNTBVAndOfferingPriceMember_ziN59HYLkvV9">5.31</td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif">$</td> <td style="width: 7%; font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90A_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zIslxeLk0VP6" style="font-size: 10pt">0.03</td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif"> </td> <td style="width: 1%; font-family: Times New Roman,serif">$</td> <td style="width: 7%; font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_90C_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember__spac--SecurityClassAxis__custom--DifferenceBetweenNTBVAndOfferingPriceMember_zoAUwgC6jznh" style="font-size: 10pt">9.97</td> <td style="width: 1%; font-family: Times New Roman,serif"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td colspan="34" style="font-family: Times New Roman,serif; text-align: center">Assuming No Exercise of Over-Allotment Option</td> <td style="font-family: Times New Roman,serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman,serif">$</td> <td style="font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90A_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--SecurityClassAxis__custom--OfferingPriceOf10.00PerUnitMember_zvpbpRf4qMv">7.77</td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif">$</td> <td style="font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90E_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_zARdzRNxJHRh" style="font-size: 10pt">7.23</td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif">$</td> <td style="font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_90A_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember__spac--SecurityClassAxis__custom--DifferenceBetweenNTBVAndOfferingPriceMember_zTPzL6hwHpec" style="font-size: 10pt">2.77</td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif">$</td> <td style="font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_906_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_zVeGGV923Ld8">6.36</td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif">$</td> <td style="font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_90A_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember__spac--SecurityClassAxis__custom--DifferenceBetweenNTBVAndOfferingPriceMember_z5Cp1lZG0Fy2">3.64</td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif">$</td> <td style="font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90A_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_zsL0QpySPck2" style="font-size: 10pt">4.66</td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif">$</td> <td style="font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_900_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember__spac--SecurityClassAxis__custom--DifferenceBetweenNTBVAndOfferingPriceMember_zRyovOAG2m4a" style="font-size: 10pt">5.34</td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif">$</td> <td style="font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90F_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zvwvnin94Zjc" style="font-size: 10pt">0.04</td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif">$</td> <td style="font-family: Times New Roman,serif; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGMpIERpbHV0aW9uAA__" id="xdx_905_espac--NetTangibleBookValueAdjustedPerShare_pid_c20251231__20251231__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember__spac--SecurityClassAxis__custom--DifferenceBetweenNTBVAndOfferingPriceMember_z10YDVL2t5M2" style="font-size: 10pt">9.96</td> <td style="font-family: Times New Roman,serif"> </td></tr> </table> 7.79 7.25 2.75 6.38 3.62 4.69 5.31 0.03 9.97 7.77 7.23 2.77 6.36 3.64 4.66 5.34 0.04 9.96 Spectre RH Limited Limited Liability Partnership The following table sets forth the payments received or to be received by our sponsor, its affiliates, from us prior to or in connection with the completion of our initial business combination and the securities issued and to be issued by us to our sponsor and its affiliates. The insider shares are identical to the public shares except for with respect to the transfer restrictions, registration rights, redemption rights, liquidating rights, and anti-dilution rights described in more detail under “— The Offering — Insider shares and letter agreement” and “Description of Securities — Ordinary Shares.” These private units are identical to the public units sold in this offering, except with respect to certain transfer restrictions and registration rights described under “— Contractual arrangements.” <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt"> <tr> <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 24%; font-family: Times New Roman,serif; text-align: center">Entity/Individual</td> <td style="text-align: center; width: 2%; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 38%; font-family: Times New Roman,serif; text-align: center">Compensation Received or to be Received or Securities Issued or to be Issued</td> <td style="text-align: center; width: 2%; font-family: Times New Roman,serif; vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; text-align: center; width: 34%; vertical-align: bottom"> Consideration Paid or to be Paid</td></tr> <tr style="background-color: white"> <td style="vertical-align: top; font-family: Times New Roman,serif">Spectre RH Limited</td> <td style="font-family: Times New Roman,serif"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_908_espac--PricePaidOrToBePaidForSecuritiesTotalAmount_c20260331__20260331__spac--SpacSponsorAffiliateOrPromoterAxis__custom--SpectreRHLimitedMember_zaLJUtPUU1Ob">10,000 per month until the closing of our initial business combination or our liquidation.</td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">Office space, utilities and secretarial and administrative support.</td></tr> <tr style="background-color: white"> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr style="background-color: white"> <td style="vertical-align: top; font-family: Times New Roman,serif">Spectre RH Limited, officers and directors </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">The sponsor and our officers and directors collectively own <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDMpIEZvcmVwYXJ0LCBTcG9uc29yIENvbXBlbnNhdGlvbgA_" id="xdx_909_espac--SecuritiesIssuedOrToBeIssuedShares_pid_c20260331__20260331__spac--SpacSponsorAffiliateOrPromoterAxis__custom--SpectreRHLimitedOfficersAndDirectorsMember__spac--CompensationNatureAxis__custom--InsiderSharesMember_fKDEp_zgUcAFrTgnL5">1,500,000 insider shares(1) if the over-allotment option is not exercised, or 1,725,000 insider shares(1) if the over-allotment option is exercised in full. These shares were issued on November 20, 2025. </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDMpIEZvcmVwYXJ0LCBTcG9uc29yIENvbXBlbnNhdGlvbgA_" id="xdx_908_espac--PricePaidOrToBePaidForSecuritiesTotalAmount_c20260331__20260331__spac--SpacSponsorAffiliateOrPromoterAxis__custom--SpectreRHLimitedOfficersAndDirectorsMember__spac--CompensationNatureAxis__custom--InsiderSharesMember_fKDEp_zWrB2vxYZ65f">25,000 in the aggregate (or approximately $0.017 per share if the over-allotment option is not exercised or approximately $0.014 per share if the over-allotment option is exercised in full).</td></tr> <tr style="background-color: white"> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr style="background-color: white"> <td style="vertical-align: top; font-family: Times New Roman,serif">Spectre RH Limited</td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDMpIEZvcmVwYXJ0LCBTcG9uc29yIENvbXBlbnNhdGlvbgA_" id="xdx_903_espac--SecuritiesIssuedOrToBeIssuedShares_pid_c20260331__20260331__spac--SpacSponsorAffiliateOrPromoterAxis__custom--SpectreRHLimitedOfficersAndDirectorsMember__spac--CompensationNatureAxis__custom--PrivateUnitsMember_fKDEp_zbICkKwQsYGf">230,000 (or <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDMpIEZvcmVwYXJ0LCBTcG9uc29yIENvbXBlbnNhdGlvbgA_" id="xdx_906_espac--SecuritiesIssuedOrToBeIssuedShares_pid_c20260331__20260331__spac--SpacSponsorAffiliateOrPromoterAxis__custom--SpectreRHLimitedOfficersAndDirectorsMember__spac--CompensationNatureAxis__custom--UnderwritersOverAllotmentOptionMember_fKDEp_zAfqxSLaeVC1">243,500 if the underwriters’ over-allotment option is exercised in full) private units to be purchased simultaneously with the closing of this offering. In addition, the <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDMpIEZvcmVwYXJ0LCBTcG9uc29yIENvbXBlbnNhdGlvbgA_" id="xdx_90E_espac--SecuritiesIssuedOrToBeIssuedShares_pid_c20260331__20260331__spac--SpacSponsorAffiliateOrPromoterAxis__custom--SpectreRHLimitedOfficersAndDirectorsMember__spac--CompensationNatureAxis__custom--PrivatePlacementWarrantsMember_fKDEp_zj3l6viewoHj">230,000 (or <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDMpIEZvcmVwYXJ0LCBTcG9uc29yIENvbXBlbnNhdGlvbgA_" id="xdx_90B_espac--SecuritiesIssuedOrToBeIssuedShares_pid_c20260331__20260331__spac--SpacSponsorAffiliateOrPromoterAxis__custom--SpectreRHLimitedOfficersAndDirectorsMember__spac--CompensationNatureAxis__custom--UnderwritersOverAllotmentOptionMember_fKDEp_zfPsZ4xCRC8d">243,500 if the underwriters’ over-allotment option is exercised in full) private placement warrants included in the private units to be purchased simultaneously with the closing of this offering may be exercised on a cashless basis, along with the public warrants under the terms of the warrant agreement, which could result in material dilution to our public shareholders.</td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDMpIEZvcmVwYXJ0LCBTcG9uc29yIENvbXBlbnNhdGlvbgA_" id="xdx_90A_espac--PricePaidOrToBePaidForSecuritiesTotalAmount_pid_c20260331__20260331__spac--SpacSponsorAffiliateOrPromoterAxis__custom--SpectreRHLimitedOfficersAndDirectorsMember__spac--CompensationNatureAxis__custom--PrivateUnitsMember_fKDEp_zPLIc0WoGxw9">2,300,000 (or $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDMpIEZvcmVwYXJ0LCBTcG9uc29yIENvbXBlbnNhdGlvbgA_" id="xdx_903_espac--PricePaidOrToBePaidForSecuritiesTotalAmount_pid_c20260331__20260331__spac--SpacSponsorAffiliateOrPromoterAxis__custom--SpectreRHLimitedOfficersAndDirectorsMember__spac--CompensationNatureAxis__custom--UnderwritersOverAllotmentOptionMember_fKDEp_zFHMHZmzHj97">2,435,000 if the underwriters’ over-allotment option is exercised in full).</td></tr> <tr style="background-color: white"> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr style="background-color: white"> <td style="vertical-align: top; font-family: Times New Roman,serif">Spectre RH Limited</td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">Up to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDMpIEZvcmVwYXJ0LCBTcG9uc29yIENvbXBlbnNhdGlvbgA_" id="xdx_908_espac--PricePaidOrToBePaidForSecuritiesTotalAmount_pid_c20260331__20260331__spac--SpacSponsorAffiliateOrPromoterAxis__custom--SpectreRHLimitedOfficersAndDirectorsMember__spac--CompensationNatureAxis__custom--LoanMember_fKDEp_zje30OXRuti8">600,000</td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">Repayment of loans made to us to cover offering related and organizational expenses.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt"> <tr style="background-color: white"> <td style="vertical-align: top; width: 24%"> Spectre RH Limited, officers, directors, or their respective affiliates</td> <td style="width: 2%; font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; width: 38%; font-family: Times New Roman,serif; text-align: justify">Repayment of working capital loans that our sponsor, officers, directors or their affiliates may, but are not obligated to, loan us from time to time, in whatever amount they deem reasonable in their sole discretion, to finance transaction costs, or the issuance of private units upon the conversion of up to $3,000,000 of such working capital loans. </td> <td style="width: 2%; font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; width: 34%; font-family: Times New Roman,serif; text-align: justify">Such loans will be repayable upon the consummation of our initial business combination, and the lender has the option to convert up to $3,000,000 of such loans into private units at a price of $10.00 per unit prior to or upon the consummation of our initial business combination. If our initial business combination is not consummated, the loans will not be repaid except to the extent that we have funds available outside of the trust account. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. </td></tr> <tr style="background-color: white"> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr style="background-color: white"> <td style="vertical-align: top; font-family: Times New Roman,serif">Spectre RH Limited, officers, directors, or their respective affiliates</td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_980_espac--SpacSponsorNatureOfReimbursement_c20260331__20260331_zMUQ0pJwcLE4" style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">Reimbursement for any out-of-pocket expenses related to identifying, investigating and competing an initial business combination.</td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">Services in connection with identifying, investigating and completing an initial business combination.</td></tr> <tr style="background-color: white"> <td style="vertical-align: top; font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr style="vertical-align: top; background-color: white"> <td style="font-family: Times New Roman,serif; text-align: justify">ARC Group Limited, an affiliate of ARC Group Securities LLC</td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif; text-align: justify">$200,000 in cash, and up to $1,000 in cash in reimbursement for expenses.</td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif; text-align: justify">Financial advisory services in connection with this offering, including market analysis, positioning, financial modeling, organizational structuring, and capital requirement assessments, as well as support throughout the public offering process, including assistance with the preparation of financial information and statements</td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt"> <tr style="vertical-align: top"> <td style="width: 0.25in; font-family: Times New Roman,serif">(1)</td> <td style="font-family: Times New Roman,serif; text-align: justify">The insider shares are subject to anti-dilution adjustments for share capitalizations, subdivision, combination or similar reclassification or recapitalization of the ordinary shares in issue into a greater or lesser number of shares occurring after the original filing of our amended and restated memorandum and articles of association. In the case that additional ordinary shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in this offering and related to or in connection with the closing of the initial business combination, the initial shareholders’ ownership will be adjusted (unless the holders of a majority of the outstanding insider shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the initial shareholders will maintain, in the aggregate, at least, twenty per cent (20%) of the sum of: (a) the total number of ordinary shares outstanding upon completion of our initial public offering (including any ordinary shares issued pursuant to the underwriter’s over-allotment option and excluding any ordinary shares underlying the private placement warrants issued to the sponsor); plus (b) all ordinary shares and equity-linked securities issued or deemed issued in connection with the closing of our initial business combination, excluding any ordinary shares or equity-linked securities issued, or to be issued, to any seller in our initial business combination and any private placement-equivalent warrants issued to the sponsor or its affiliates or to the Company’s officers and directors upon the conversion of working capital loans made to the Company; minus (c) the number of public shares redeemed in connection with our initial business combination or an amendment to our amended and restated memorandum and articles of association.</td></tr> </table> 10000 1500000 25000 230000 243500 230000 243500 2300000 2435000 600000 Reimbursement for any out-of-pocket expenses related to identifying, investigating and competing an initial business combination. 7.79 7.25 2.75 6.38 3.62 4.69 5.31 0.03 9.97 7.77 7.23 2.77 6.36 3.64 4.66 5.34 0.04 9.96 <div id="xdx_892_espac--ConflictOfInterestDescriptionTextBlock_zd3eFTxSeKI8" style="border: Black 1pt solid; padding-right: 6pt; padding-left: 6pt"> Conflicts of Interest <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyLCBTUEFDIFJlZ2lzdGVyZWQgT2ZmZXJpbmdzAA__" id="xdx_90E_espac--SpacOfferingForepartActualOrMaterialConflictOfInterestFlag_dbT_c20260331__20260331_zpFbxxOfgUB7">Potential investors should be aware that there are actual or potential material conflicts of interest between (i) our sponsor, officers, directors, promotors and their respective affiliates and (ii) our unaffiliated security holders (including purchasers of the public units being sold in this offering) with respect to determining whether to proceed with a de-SPAC transaction and the manner in which we compensate our sponsor, officers, directors, promotors and their respective affiliates. Because of the financial and personal interests described below, our sponsor, officers and directors may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination and the terms on which we will complete such business combination, and they may be incentivized to (i) pursue a target company that has a less favorable risk, stability or profitability profile for our public shareholders but would be easier, quicker and more certain to guide through the business combination process over a target company that has a better risk, stability or profitability profile for our public shareholders but may take a longer time to diligence and go through the business combination process or (ii) effect our initial business combination with less desirable terms and conditions in order complete a business combination within the required period, both of which could cause our public shareholders to experience a negative rate of return or lose significant value on their shares of the combined company. Further, each of our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination. <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt"> <tr> <td style="width: 0.25in; font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; width: 0.25in; font-family: Times New Roman,serif; text-align: justify">●</td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">On November 20, 2025, our sponsor purchased an aggregate of 1,725,000 insider shares for an aggregate of $25,000 (or approximately $0.014 per share), up to 225,000 of which will be surrendered to us for no consideration after the closing of this offering depending on the extent to which the underwriters’ over-allotment option is exercised. Our sponsor has also committed to purchasing from us an aggregate of 230,000 private units (or up to 243,500 private units if the underwriters’ over-allotment option is exercised) at $10.00 per private unit for a total purchase price of $2,300,000 (or up to $2,435,000 if the underwriters’ over-allotment option is exercised) simultaneously with the consummation of this offering. Upon consummation of our offering and the private placement, assuming our sponsor, officers and directors do not purchase additional units or shares, our sponsor, officer and directors will own 1,500,000 of our issued and outstanding shares immediately after this offering, if the underwriters’ over-allotment option is not exercised, or 1,725,000 of our issued and outstanding shares immediately after this offering if the underwriters’ over-allotment option is fully exercised.</td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">●</td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">On November 17, 2025, we issued an unsecured promissory note to our sponsor with an aggregate principal amount of up to $350,000, which is non-interest-bearing. On December 16, 2025, we amended and restated the note by issuing an amended and restated promissory note, increasing the principal amount to $600,000. The principal of this note may be drawn down from time to time upon a written request from us to our sponsor. The principal under the note is payable on the date on which we consummate the initial public offering of our securities or the date on which we determine not to conduct an initial public offering of our securities. As of December 31, 2025, the Company has borrowed $95,674 under the promissory note with our Sponsor.</td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">●</td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">If a business combination is completed, based on the difference between the nominal purchase price our sponsor, officers and directors paid for the insider shares and our public shareholders’ purchase price of $10.00 per unit sold in the offering, our sponsor, officers and directors may earn a positive rate of return even if the share price of the combined company falls below the price our public shareholders paid for the units in this offering and our public shareholders experience a negative rate of return or lose significant value on the shares of the combined company. If the over-allotment option is not exercised, our sponsor, officers and directors can recoup their investment in their insider shares as long as the combined company’s stock trades at or above $0.017 per share and our sponsor can recoup its investment in its insider shares and private shares as long as the combined company’s shares trade at or above $1.34 per share. If the over-allotment option is exercised in full, our sponsor, officers and directors can recoup their investment in their insider shares as long as the combined company’s stock trades at or above $0.015 per share and our sponsor can recoup its investment in its insider shares and private shares as long as the combined company’s stock trades at or above $1.25 per share. The nominal price at which the insider shares were issued also results in a substantial dilution to our public shareholders. For more details, see “Dilution.”</td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">●</td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">On the other hand, if we fail to complete a business combination within the required period, we will cease all operations except for the purpose of winding up, distribute the aggregate amount then on deposit in the trust account, including interest (net of taxes payable and up to $100,000 of interest to pay dissolution expenses), pro rata to our public shareholders, by way of the redemption of their shares, and, subject to the approval of our remaining shareholders and our board of directors, dissolve and liquidate. In such event, the insider shares and private units held by our sponsor, officers and directors would be worthless and they will lose their entire investment, except to the extent they receive liquidating distributions from assets outside the trust account, because (A) they have agreed, pursuant to a letter agreement with us, to (i) waive any right to exercise redemption rights with respect to any ordinary shares beneficially owned or to be owned by them, directly or indirectly, whether acquired before, in, or after the IPO (or to sell such shares to our company in a tender offer), (ii) waive any and all Claims with respect to their insider shares and private shares any Claim they may have in the future as a result of, or arising out of, any contracts or agreements with us and to not seek recourse against the trust account for any reason whatsoever, although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete our initial business combination within the required period and to liquidating distributions from assets outside the trust account, and (iii) subject their insider shares, ordinary shares issuable upon conversion thereof, and the private units and their component securities to the aforementioned transfer restrictions; and (B) the sponsor will not receive any of such funds for the warrants it purchased as part of its private units and these warrants will expire worthless.</td></tr> </table> </div> <div style="border: Black 1pt solid; padding-right: 6pt; padding-left: 6pt"> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt"> <tr> <td style="width: 0.25in; font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; width: 0.25in; font-family: Times New Roman,serif; text-align: justify">●</td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">The insider shares are identical to the public shares except for with respect to the transfer restrictions, registration rights, redemption rights, liquidating rights, and anti-dilution rights. For more details, see “Prospectus Summary — The Offering — Insider shares and letter agreement” and “Description of Securities — Ordinary Shares.”</td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">●</td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">In the event that following this offering we obtain working capital loans from our sponsor, officers, directors or their affiliates to finance transaction costs related to our initial business combination, such loans will be repayable upon the consummation of our initial business combination, and the lender has the option to convert up to $3,000,000 of such loans into private units at a price of $10.00 per unit prior to or upon the consummation of our initial business combination. If a business combination is not consummated, the loans will not be repaid except to the extent that we have funds available outside of the trust account. In addition, the conversion price for such working capital loans may potentially be significantly less than the market price of our shares at the time the lender elects to convert its working capital loans into private units. Further, the issuance of additional ordinary shares underlying these units will increase the number of issued and outstanding ordinary shares, result in a material dilution to the equity interests of our public shareholders and reduce the value of our public shares, which could make it more difficult to effect a business combination or obtain future financing.</td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">●</td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">Pursuant to the Administrative Support Agreement, we will pay to our sponsor $10,000 per month for certain utilities and secretarial and administrative support as may be reasonably required by the Company that the sponsor shall make available, or cause to be made available, to our company or successor until the closing of our initial business combination or our liquidation, and the sponsor has waived (i) any Claim in or to, and any and all right to seek payment of any amounts due to it out of, the trust account as a result of, or arising out of, the agreement and (ii) any Claim it may have in the future, which Claim would reduce, encumber or otherwise adversely affect the trust account or any monies or other assets in the trust account, and agrees not to seek recourse, reimbursement, payment or satisfaction of any Claim against the trust account or any monies or other assets in the trust account for any reason whatsoever.</td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">●</td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">While our sponsor, officers, directors or their affiliates may receive reimbursement from us for reasonable out-of-pocket expenses related to identifying, investigating, negotiating and completing an initial business combination from funds held outside the trust account prior to the completion of our initial business combination, no reimbursement may be made from the proceeds held in the trust account prior to the completion of a business combination. If we fail to consummate a business combination within the required period, these persons will not have any claim against the trust account for reimbursement or receive any reimbursement.</td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif">●</td> <td style="font-family: Times New Roman,serif; text-align: justify">Our sponsor has engaged ARC Group Limited, an affiliate of ARC Group Securities LLC, to provide financial advisory services in connection with this offering. These services include market analysis, positioning, financial modeling, organizational structuring, and capital requirement assessments, as well as support throughout the public offering process, including assistance with the preparation of financial information and statements. According to the engagement letter, between an affiliate of our sponsor and ARC Capital, an affiliate of ARC Group Limited, dated October 17, 2025, ARC Group Limited has received $50,000 compensation in cash for its services and will receive a further $150,000 compensation in cash for its services upon the successful completion of the offering and will be reimbursed for certain of its expenses in an amount not to exceed $1,000, and such cash compensation will not result in a material dilution of your equity interest. There is no actual or potential material conflict of interest between the advisor and any purchaser in the offering as a result of this affiliation.</td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">●</td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">In the event of the liquidation of the trust account, our sponsor has agreed to indemnify and hold harmless our company for any debts and obligations to target businesses or vendors or other entities that are owed money by us for services rendered or contracted for or products sold to us, but only to the extent necessary to ensure that such debt or obligation does not reduce the amount of funds in the trust account below $10.00 per share and provided that such indemnity shall not apply if such vendor or prospective target business executed an agreement waiving any right, title, interest or claim of any kind they may have in or to any monies held in the trust account.</td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">●</td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">We are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, officers and directors or their affiliates, nor are we prohibited from consummating a business combination where any of our sponsor, officers and directors or their affiliates acquire a minority interest in the target business alongside our acquisition, provided that such transaction must be approved by a majority of our independent directors who do not have an interest in such transaction. Accordingly, such affiliated person(s) may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination and the terms on which we will complete such business combination as such affiliated person(s) would have interests different from our public shareholders and would likely not receive any financial benefit unless we consummated such business combination. Unless our board is unable to independently determine the fair market value of a target business or businesses, or the target is affiliated with our sponsor, officers and directors or their affiliates, we are not required to obtain an opinion from an independent investment banking firm or another independent entity that commonly renders valuation opinions that the price we are paying is fair to our company from a financial point of view. If no opinion is obtained, our shareholders will be relying on the judgment of our board of directors, who will determine fair market value based on standards generally accepted by the financial community. Such standards used will be disclosed in our proxy materials or tender offer documents, as applicable, related to our initial business combination.</td></tr> </table> </div> <table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt"> <tr> <td style="width: 0.25in; font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; width: 0.25in; font-family: Times New Roman,serif">●</td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">Our officers and directors will be able to remain with the combined company only if they are able to negotiate employment or consulting agreements or other arrangements in connection with the business combination. Such negotiations would take place simultaneously with the negotiation of the business combination and could provide for such individuals to receive compensation in the form of cash payments and/or our securities for services they would render to the Company after the consummation of the business combination. The personal and financial interests of such individuals may influence their motivation in identifying and selecting a target business.</td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="font-family: Times New Roman,serif"> </td> <td style="font-family: Times New Roman,serif; text-align: justify"> </td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif">●</td> <td style="vertical-align: top"> Each of our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination. </td></tr> <tr> <td style="font-family: Times New Roman,serif; text-align: justify"> </td> <td style="vertical-align: top; font-family: Times New Roman,serif">●</td> <td style="vertical-align: top; font-family: Times New Roman,serif; text-align: justify">Our officers and directors are not required to commit their full time to our affairs, and certain of our officers and directors presently have, and any of them in the future may have, additional, fiduciary, contractual or other obligations or duties to one or more other entities. Accordingly, if such officers or directors become aware of a business combination opportunity which is suitable for one or more entities to which he or she has fiduciary, contractual or other obligations or duties, he or she will honor these obligations and duties to present such business combination opportunity to such entities, and may only present it to us if such entities reject the opportunity and he or she determines to present the opportunity to us. These conflicts may not be resolved in our favor and a potential target business may be presented to another entity prior to its presentation to us. If our officers and directors are required to devote more substantial amounts of time to their other business affairs or present a business combination opportunity to such entities, our ability to consummate our initial business combination could be materially and adversely affected. </td></tr> </table> We cannot assure you that any of the conflicts mentioned above will be resolved in our favor. Other than the payments described above, our sponsor, officers and directors have agreed pursuant to the letter agreement that they and their affiliates will not receive and will not accept a finder’s fee or any other compensation prior to, or for services rendered in order to effectuate, the consummation of our initial business combination. true Potential Additional Financings We may need to obtain additional financing to complete our initial business combination, either because the transaction requires more cash than is available from the proceeds held in our trust account or because we become obligated to redeem a significant number of our public shares upon completion of the business combination, in which case we may issue additional securities or incur debt in connection with such business combination. If we raise additional funds through equity or convertible debt issuances, our public shareholders may suffer significant dilution and these securities could have rights that rank senior to our public shares. If we raise additional funds through the incurrence of indebtedness, such indebtedness would have rights that are senior to our equity securities and could contain covenants that restrict our operations. Further, as described above, due to the anti-dilution rights of our initial shares, our public shareholders may incur material dilution. In addition, we intend to target businesses with enterprise values that are greater than we could acquire with the net proceeds of this offering and the sale of the private units, and, as a result, if the cash portion of the purchase price exceeds the amount available from the trust account, net of amounts needed to satisfy any redemptions by public shareholders, we may be required to seek additional financing to complete such proposed initial business combination. We may also obtain financing prior to the closing of our initial business combination to fund our working capital needs and transaction costs in connection with our search for and completion of our initial business combination. These financing transactions are typically designed to ensure a return on investment to the investor in exchange for assisting the Company in completing the business combination or providing sufficient liquidity to the combined company. The price of the shares we issue may therefore be lower, and potentially significantly lesser, than the market price for our shares at such time. These financing transactions may be significantly dilutive to the combined company, and represent the type of financing risk that is not associated with traditional initial public offerings. Any such additional financing, including issuance of equity or convertible securities, may significantly dilute the interests of our public shareholders. There is no limitation on our ability to raise funds through the issuance of equity or equity-linked securities or through loans, advances or other indebtedness in connection with our initial business combination, including pursuant to forward purchase agreements or backstop agreements we may enter into following consummation of this offering. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our initial business combination. If we are unable to complete our initial business combination because we do not have sufficient funds available to us, we will be forced to liquidate the trust account. In addition, following our initial business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations. 6,000,000 units (or 6,900,000 units if the underwriter’s over-allotment option is exercised in full), at $10.00 per unit, each unit consisting of:● one ordinary share, and ● one redeemable warrant. Nasdaq rules provide that at least <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyLCBTUEFDIFJlZ2lzdGVyZWQgT2ZmZXJpbmdzAA__" id="xdx_90D_espac--SpacTrustOrEscrowAccountGrossOfferingProceedsPlacedPercent_dp_uPure_c20260331__20260331_zbJ7VEG7tJQ9">90% of the gross proceeds from this offering and the sale of the private units be deposited in a trust account. Of the net proceeds of this offering and the sale of the private units, $60,000,000 or $10.00 per unit ($69,000,000, if the underwriters’ over-allotment option is exercised in full) will be placed into a U.S.-based trust account at JP Morgan Chase & Co. with Efficiency, acting as trustee. The remaining net proceeds of this offering and the sale of the private units will not be held in the trust account.Except for interest earned on the funds in the trust account that may be released to us to pay our tax obligations, the proceeds held in the trust account will not be released until the earlier of: (i) the completion of our initial business combination within the required period; (ii) our redemption of public shares if we have not completed an initial business combination within the required period; (iii) our redemption of public shares in connection with an amendment to our amended and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 18 months from the closing of this initial public offering, subject to extension up to 21 months by means of three one-month extensions provided that $0.033 per public share is deposited into the trust account for each one-month extension and further provided that the Company has entered into an agreement for an initial business combination within that 18-month period, or (B) with respect to any other provision of our amended and restated memorandum and articles of association relating to the rights of public shareholders or pre-business combination activity; and (iv) our liquidation. Therefore, unless and until our initial business combination is consummated, the proceeds held in the trust account will not be available for our use for any expenses related to this offering or expenses which we may incur related to the investigation and selection of a target business and the negotiation of an agreement in connection with our initial business combination. Notwithstanding the foregoing, there will be released to us from the trust account any interest earned on the funds in the trust account that we need to pay our income or other tax obligations. With these exceptions, expenses incurred by us may be paid prior to a business combination only from the net proceeds of this offering not held in the trust account (estimated to initially be $800,000); provided, however, that in order to meet our working capital needs following the consummation of this offering until the completion of an initial business combination, our sponsor, officers and directors or their affiliates may, but are not obligated to, loan us funds, from time to time, in whatever amount they deem reasonable in their sole discretion. Such loans will be repayable upon the consummation of our initial business combination, and the lender has the option to convert up to $3,000,000 of such loans into private units at a price of $10.00 per unit prior to or upon the consummation of our initial business combination. If a business combination is not consummated, the loans will not be repaid except to the extent that we have funds available outside of the trust account. 0.90 60000000 true true There are actual or potential material conflicts of interest between (i) our sponsor, officers, directors, promotors and their respective affiliates and (ii) our unaffiliated security holders (including purchasers of the public units being sold in this offering) with respect to determining whether to proceed with a de-SPAC transaction and the manner in which we compensate our sponsor, officers, directors, promotors and their respective affiliates. Because of the financial and personal interests described in more detail under “Our Sponsor, Officers and Directors — Conflicts of interest” on page 10, our sponsor, officers and directors may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination and the terms on which we will complete such business combination, and they may be incentivized to (i) pursue a target company that has a less favorable risk, stability or profitability profile for our public shareholders but would be easier, quicker and more certain to guide through the business combination process over a target company that has a better risk, stability or profitability profile for our public shareholders but may take a longer time to diligence and go through the business combination process or (ii) effect our initial business combination with less desirable terms and conditions in order complete a business combination within the required period, both of which could cause our public shareholders to experience a negative rate of return or lose significant value on their shares of the combined company. Further, each of our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination. In addition, conflicts of interest may arise because our officers and directors are not required to commit their full time to our affairs, and, as described in “Management — Conflicts of Interest” on page 138, certain of our officers and directors presently have, and any of them in the future may have, additional, fiduciary, contractual or other obligations or duties to one or more other entities. Accordingly, if such officers or directors become aware of a business combination opportunity which is suitable for one or more entities to which he or she has fiduciary, contractual or other obligations or duties, he or she will honor these obligations and duties to present such business combination opportunity to such entities, and may only present it to us if such entities reject the opportunity and he or she determines to present the opportunity to us. These conflicts may not be resolved in our favor and a potential target business may be presented to another entity prior to its presentation to us. If our officers and directors are required to devote more substantial amounts of time to their other business affairs or present a business combination opportunity to such entities, our ability to consummate our initial business combination could be materially and adversely affected. For more details on related risks, see the sections titled “Risk Factors — Risks Associated with Our Business and Securities — The financial and personal interests of our sponsor, officers and directors may influence their motivation in determining whether a particular target business is appropriate for a business combination” on page 49, “Risk Factors — Risks Associated with Our Business and Securities — We may acquire a target business that is affiliated with our sponsor, officers and directors or their affiliates” on page 52, “Risk Factors — Risks Associated with Our Business and Securities — We are not required to obtain a fairness opinion unless our board is unable to independently determine the fair market value of a target business or businesses. Consequently, you may have no assurance from an independent source that the price we are paying for the business is fair to our company from a financial point of view” on page 53, “Risk Factors — Risks Associated with Our Business and Securities — Our officers and directors may negotiate employment or consulting agreements with a target business in connection with a particular business combination. These agreements may provide for them to receive compensation following a business combination and as a result, may cause them to have conflicts of interest in determining whether a particular business combination is the most advantageous” on page 53, “Risk Factors — Risks Associated with Our Business and Securities — Our officers and directors will allocate their time to other businesses, including those that are similar in nature to ours, thereby potentially limiting the amount of time they devote to our affairs. This conflict of interest could have a negative impact on our ability to consummate our initial business combination” on page 48, “Risk Factors — Risks Associated with Our Business and Securities — Certain of our officers and directors presently have, and any of them in the future may have, additional, fiduciary, contractual or other obligations or duties and accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented” on page 49 and “Risk Factors — Risks Associated with Our Business and Securities — Certain of our officers and directors may in the future become, affiliated with entities engaged in business activities similar to those intended to be conducted by us and, accordingly, may have conflicts of interest in allocating their time and determining to which entity a particular business opportunity should be presented” on page 48. true The difference between the public offering price per share of ordinary shares, assuming no value is attributed to the units included in the units we are offering pursuant to this prospectus or the private units, and the pro forma net tangible book value per share of our ordinary shares after this offering constitutes the dilution to investors in this offering. Net tangible book value per share is determined by dividing our net tangible book value, which is our total tangible assets, less total liabilities (including the value of ordinary shares which may be redeemed for cash), by the number of issued and outstanding ordinary shares. 7.79 7.25 2.75 6.38 3.62 4.69 5.31 0.03 9.97 7.77 7.23 2.77 6.36 3.64 4.66 5.34 0.04 9.96 <p id="xdx_89F_espac--SpacAdjustedNetTangibleBookValuePerShareWithSourcesOfDilutionTableTextBlock_dU_z4ePccG7z51i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> The following tables illustrate the dilution to the public shareholders on a per-share basis: Assumes Full Exercise of Over-Allotment Option <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20251231__20251231__spac--SecurityClassAxis__custom--FullOverAllotmentMember__spac--RedemptionLevelAxis__spac--NoRedemptionMember_zpc1rPdp47X" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">No Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20251231__20251231__spac--SecurityClassAxis__custom--FullOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_zJoKcZmmB6Oc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">25% of Maximum Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_493_20251231__20251231__spac--SecurityClassAxis__custom--FullOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_z4h2an0hV4Gb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">50% of Maximum Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20251231__20251231__spac--SecurityClassAxis__custom--FullOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_zBSAqgFSLP7h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">75% of Maximum Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20251231__20251231__spac--SecurityClassAxis__custom--FullOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zWP3xZ8qTymi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Maximum Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%">Public offering price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_espac--NetTangibleBookValuePreTransactionPerShare_pid_uUSDShares_zwCHAMfeQlUl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">NTBV per share before this offering</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Increase attributable to this offering and private placement</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7.90</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7.36</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.49</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4.80</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.14</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_espac--NetTangibleBookValueAdjustedPerShare_pid_uUSDShares_zd3Dw259RuK4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Pro forma NTBV after this offering *</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7.79</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7.25</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.38</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4.69</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.03</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_espac--NetTangibleBookValueAmountOfDilutionPerShare_pid_uUSDShares_zjg7rdR6gWLl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Dilution to public shareholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.21</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.75</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3.62</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5.31</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9.97</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Percentage of dilution to public shareholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">22.1</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27.5</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">36.2</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">53.1</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">99.7</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">*</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">See following table for numerator of the pro forma net tangible book value divided by denominator of the shares outstanding. We assume the net tangible book value before this offering will be increased by net proceeds from this offering and offering costs accrued in advance but further set off by deferred underwriting commissions and proceeds held in trust subject to redemption.</td></tr> </table> Assuming No Exercise of Over-Allotment Option <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20251231__20251231__spac--SecurityClassAxis__custom--NoOverAllotmentMember__spac--RedemptionLevelAxis__spac--NoRedemptionMember_ztnsbC3yVHue" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">No Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20251231__20251231__spac--SecurityClassAxis__custom--NoOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_z0LDaeyCZCPh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">25% of Maximum Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20251231__20251231__spac--SecurityClassAxis__custom--NoOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_z3WtUVZsfCM5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">50% of Maximum Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20251231__20251231__spac--SecurityClassAxis__custom--NoOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_zgvgj9hla9wj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">75% of Maximum Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20251231__20251231__spac--SecurityClassAxis__custom--NoOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zoukoX2lQJ85" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Maximum Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 30%">Public offering price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_espac--NetTangibleBookValuePreTransactionPerShare_pid_uUSDShares_z1v1mErwZIc1" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">NTBV per share before this offering</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Increase attributable to this offering and private placement</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7.88</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7.34</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.47</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4.77</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.15</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_espac--NetTangibleBookValueAdjustedPerShare_pid_uUSDShares_zEa2mmHoS2gi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Pro forma NTBV after this offering**</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7.77</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7.23</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.36</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4.66</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.04</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_espac--NetTangibleBookValueAmountOfDilutionPerShare_pid_uUSDShares_zyk8eeBNXHX9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Dilution to public shareholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.23</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.77</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3.64</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5.34</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9.96</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Percentage of dilution to public shareholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">22.3</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27.7</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">36.4</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">53.4</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">99.6</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">**</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">See following table for numerator of the pro forma net tangible book value divided by denominator of the shares outstanding. We assume the net tangible book value before this offering will be increased by net proceeds from this offering and offering costs accrued in advance but further set off by deferred underwriting commissions and proceeds held in trust subject to redemption.</td></tr> </table> The pro forma NTBV per share after this offering for each of the redemption scenarios is calculated as follows: Assuming Full Exercise of Over-Allotment Option <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" id="xdx_49B_20251231__20251231__spac--SecurityClassAxis__custom--FullOverAllotmentMember__spac--RedemptionLevelAxis__spac--NoRedemptionMember_zkI78EZHmGwi" style="font-weight: bold; font-style: italic; text-align: center">No</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" id="xdx_498_20251231__20251231__spac--SecurityClassAxis__custom--FullOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_z0BEPRB7DcD5" style="font-weight: bold; font-style: italic; text-align: center">25% (1)</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" id="xdx_490_20251231__20251231__spac--SecurityClassAxis__custom--FullOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_zavyMAa22992" style="font-weight: bold; font-style: italic; text-align: center">50% (2)</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" id="xdx_49B_20251231__20251231__spac--SecurityClassAxis__custom--FullOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_zOLAH7epmIP3" style="font-weight: bold; font-style: italic; text-align: center">75% (3)</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" id="xdx_493_20251231__20251231__spac--SecurityClassAxis__custom--FullOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zfldPxcpcjhb" style="font-weight: bold; font-style: italic; text-align: center">100% (4)</td><td style="font-weight: bold; font-style: italic"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025*</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" style="font-weight: bold; font-style: italic; text-align: center">Scenario</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" style="font-weight: bold; font-style: italic; text-align: center">Scenario A</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" style="font-weight: bold; font-style: italic; text-align: center">Scenario B</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" style="font-weight: bold; font-style: italic; text-align: center">Scenario C</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" style="font-weight: bold; font-style: italic; text-align: center">Scenario D</td><td style="font-weight: bold; font-style: italic"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" style="font-weight: bold; font-style: italic; text-align: center">No</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" style="font-weight: bold; font-style: italic; text-align: center">25%</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" style="font-weight: bold; font-style: italic; text-align: center">50%</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" style="font-weight: bold; font-style: italic; text-align: center">75%</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" style="font-weight: bold; font-style: italic; text-align: center">100%</td><td style="font-weight: bold; font-style: italic"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">Redemptions(1)</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">Redemptions(2)</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">Redemptions(3)</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; font-style: italic; text-align: center">Redemptions(4)</td><td style="padding-bottom: 1pt; font-weight: bold; font-style: italic"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="18">*The pro forma net tangible book value per share after the offering is calculated as follows</td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_espac--NetTangibleBookValue_zJqMWiaJfSdc" style="vertical-align: bottom; background-color: White"> <td style="width: 30%; text-align: left">Net tangible book value before this offering</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(193,642</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(193,642</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(193,642</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(193,642</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(193,642</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_40E_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--NetProceedsFromThisOfferingAndTheSaleOfPrivateUnitsMember_zdgD91SEYm8k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net proceeds from this offering and sale of the private units, net of expenses(9)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">69,800,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">69,800,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">69,800,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">69,800,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">69,800,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--OfferingCostsAccruedForAndPaidInAdvanceExcludedFromTangibleBookValueMember_zl6BZJE9Q0E" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Plus: Offering costs accrued in advance, excluded from tangible book value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,529</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,529</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,529</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,529</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,529</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--DeferredUnderwritingCommissionsMember_zSEVvUhnO7N5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: Deferred underwriting commissions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(690,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(690,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(690,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(690,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(690,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_401_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--ProceedsSubjectToRedemptionMember_z0cldu1NwFK6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Proceeds held in trust subject to redemption (10)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(17,250,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(34,500,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(51,750,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(69,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40C_espac--NetTangibleBookValueAdjusted_zkRYCBXBlZel" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">69,059,887</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">51,809,887</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">34,559,887</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">17,309,887</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">59,887</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_espac--NumberOfSharesUsedAdjustment_pid_hspac--DilutionSourceAxis__custom--OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember_zeThPA3n4zng" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Ordinary shares issued and outstanding prior to this offering</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_407_espac--NumberOfSharesUsedAdjustment_pid_hspac--DilutionSourceAxis__custom--OrdinarySharesIncludedInPublicUnitsOfferedMember_z7ZpQIZ9hUvj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Ordinary shares included in the public units offered</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,900,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,900,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,900,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,900,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,900,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_espac--NumberOfSharesUsedAdjustment_pid_hspac--DilutionSourceAxis__custom--OrdinarySharesIncludedInPrivateUnitsMember_zoB3NITHpsk4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Ordinary shares included in the private units</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">243,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">243,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">243,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">243,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">243,500</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_espac--NumberOfSharesUsedAdjustment_iN_pid_di_hspac--DilutionSourceAxis__custom--OrdinarySharesSubjectToRedemptionMember_zN1d07ohELX4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Ordinary shares subject to redemption</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,725,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,450,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(5,175,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(6,900,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_espac--NumberOfSharesUsedAdjustment_pid_zzQe0faSTi65" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">8,868,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,143,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">5,418,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,693,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,968,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The numbers set forth in this column assume that 1,725,000 public shares, or 25% of 6,900,000 public shares, are redeemed.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The numbers set forth in this column assume that 3,450,000 public shares, or 50% of 6,900,000 public shares, are redeemed.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The numbers set forth in this column assume that 5,175,000 public shares, or 75% of 6,900,000 public shares, are redeemed.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(4)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The numbers set forth in this column assume that 6,900,000 public shares or 100% of 6,900,000 public shares are redeemed.</td></tr> </table> Assuming No Exercise of Over-Allotment Option <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" id="xdx_491_20251231__20251231__spac--SecurityClassAxis__custom--NoOverAllotmentMember__spac--RedemptionLevelAxis__spac--NoRedemptionMember_zWonhFM58Oi7" style="font-weight: bold; font-style: italic; text-align: center">No</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" id="xdx_495_20251231__20251231__spac--SecurityClassAxis__custom--NoOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_zfGahXgciTK" style="font-weight: bold; font-style: italic; text-align: center">25% (5)</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" id="xdx_49E_20251231__20251231__spac--SecurityClassAxis__custom--NoOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_z6zs1jVVsayh" style="font-weight: bold; font-style: italic; text-align: center">50% (6)</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" id="xdx_49A_20251231__20251231__spac--SecurityClassAxis__custom--NoOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_zVpdC34yaz39" style="font-weight: bold; font-style: italic; text-align: center">75% (7)</td><td style="font-weight: bold; font-style: italic"> </td><td style="font-weight: bold; font-style: italic"> </td> <td colspan="2" id="xdx_495_20251231__20251231__spac--SecurityClassAxis__custom--NoOverAllotmentMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zpW4j3IhYmQg" style="font-weight: bold; font-style: italic; text-align: center">100% (8)</td><td style="font-weight: bold; font-style: italic"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="18" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of December 31, 2025**</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Scenario No redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Scenario A 25% redemptions(5)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Scenario B 50% redemptions(6)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Scenario C 75% redemptions(7)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Scenario D 100% redemptions(8)</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="18" style="text-align: justify">*The pro forma net tangible book value per share after the offering is calculated as follows</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_espac--NetTangibleBookValue_zlEuCRaR4gK5" style="vertical-align: bottom; background-color: White"> <td style="width: 30%; text-align: left">Net tangible book value before this offering</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(193,642</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(193,642</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(193,642</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(193,642</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(193,642</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_408_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--NetProceedsFromThisOfferingAndTheSaleOfPrivateUnitsMember_zInhS0MwF94c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net proceeds from this offering and sale of the private units, net of expenses(9)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">60,800,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">60,800,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">60,800,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">60,800,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">60,800,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--OfferingCostsAccruedForAndPaidInAdvanceExcludedFromTangibleBookValueMember_ziEeNG0nrLU9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Plus: Offering costs accrued in advance, excluded from tangible book value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,529</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,529</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,529</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,529</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143,529</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--DeferredUnderwritingCommissionsMember_zekngG271d79" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: Deferred underwriting commissions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(600,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(600,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(600,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(600,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(600,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--OverallotmentLiabilityMember_zrBGu7ok3wlf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: Over-allotment liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(87,030</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(87,030</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(87,030</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(87,030</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(87,030</td><td style="text-align: left">)</td></tr> <tr id="xdx_406_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--ProceedsSubjectToRedemptionMember_zWYFSFZD5Ey6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Proceeds held in trust subject to redemption (10)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(15,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(30,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(45,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(60,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40D_espac--NetTangibleBookValueAdjusted_zV2QAh30N51f" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">60,062,857</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">45,062,857</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">30,062,857</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,062,857</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">62,857</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_espac--NumberOfSharesUsedAdjustment_pid_hspac--DilutionSourceAxis__custom--OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember_zTofdlkdqS4l" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Ordinary shares issued and outstanding prior to this offering</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,500,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_espac--NumberOfSharesUsedAdjustment_pid_hspac--DilutionSourceAxis__custom--OrdinarySharesIncludedInPublicUnitsOfferedMember_z9Uu7QK9isKj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Ordinary shares included in the public units offered</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_espac--NumberOfSharesUsedAdjustment_pid_hspac--DilutionSourceAxis__custom--OrdinarySharesIncludedInPrivateUnitsMember_zDpt6XIARA1b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Ordinary shares included in the private units</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">230,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">230,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">230,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">230,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">230,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_espac--NumberOfSharesUsedAdjustment_iN_pid_di_hspac--DilutionSourceAxis__custom--OrdinarySharesSubjectToRedemptionMember_zJ71fgCTHrF" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Ordinary shares subject to redemption</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,500,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(3,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4,500,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(6,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_404_espac--NumberOfSharesUsedAdjustment_pid_zcPRkbAJuGH6" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">7,730,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">6,230,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">4,730,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">3,230,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,730,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(5)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The numbers set forth in this column assume that 1,500,000 public shares, or 25% of 6,000,000 public shares, are redeemed.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(6)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The numbers set forth in this column assume that 3,000,000 public shares, or 50% of 6,000,000 public shares, are redeemed.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(7)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The numbers set forth in this column assume that 4,500,000 public shares, or 75% of 6,000,000 public shares, are redeemed.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(8)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The numbers set forth in this column assume that 6,000,000 public shares, or 100% of 6,000,000 public shares are redeemed.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(9)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The numbers set forth in this row assume that $60,000,000 will be held in the trust account (or $69,000,000 if the underwriter’s over-allotment option is fully exercised) plus $800,000 in working capital held outside the trust account immediately after the offering. See “Use of Proceeds.”</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(10)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our sponsor, directors, executive officers, advisors or any of their affiliates may purchase public shares or public units in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination. In the event of any such purchases of our shares prior to the completion of our initial business combination, the number of ordinary shares subject to redemption will be reduced by the amount of any such purchases, increasing the pro forma net tangible book value per share. See “Proposed Business — Effecting Our Initial Business Combination — Permitted purchases of our securities by our affiliates.”</td></tr> </table> -0.11 -0.11 -0.11 -0.11 -0.11 7.79 7.25 6.38 4.69 0.03 2.21 2.75 3.62 5.31 9.97 -0.11 -0.11 -0.11 -0.11 -0.11 7.77 7.23 6.36 4.66 0.04 2.23 2.77 3.64 5.34 9.96 -193642 -193642 -193642 -193642 -193642 69800000 69800000 69800000 69800000 69800000 143529 143529 143529 143529 143529 -690000 -690000 -690000 -690000 -690000 -17250000 -34500000 -51750000 -69000000 69059887 51809887 34559887 17309887 59887 1725000 1725000 1725000 1725000 1725000 6900000 6900000 6900000 6900000 6900000 243500 243500 243500 243500 243500 1725000 3450000 5175000 6900000 8868500 7143500 5418500 3693500 1968500 -193642 -193642 -193642 -193642 -193642 60800000 60800000 60800000 60800000 60800000 143529 143529 143529 143529 143529 -600000 -600000 -600000 -600000 -600000 -87030 -87030 -87030 -87030 -87030 -15000000 -30000000 -45000000 -60000000 60062857 45062857 30062857 15062857 62857 1500000 1500000 1500000 1500000 1500000 6000000 6000000 6000000 6000000 6000000 230000 230000 230000 230000 230000 1500000 3000000 4500000 6000000 7730000 6230000 4730000 3230000 1730000 In addition to the potential dilution reflected in the table above, there are several material sources of future dilution that may occur following this offering. For example, prior to, in connection with, or after our initial business combination, we may issue additional ordinary shares or other equity securities to raise capital, to fulfill our obligations under working capital loans that we may obtain from our sponsor, officers, directors or their affiliates (should the lender elect to convert up to $3,000,000 of such loans into private units at a price of $10.00 per unit), or under an employee incentive plan that is intended to attract and retain management, employees and advisors. The issuance of additional ordinary or other equity securities may significantly dilute the equity interest of investors in this offering. If such issuances are made at prices below the market value or net tangible book value of our shares at the time of issuance, the equity interest of investors in this offering will be further diluted. Redemption rights for public shareholders upon consummation of our initial business combination We will provide our public shareholders who are not our sponsor, directors or officers with the opportunity to redeem all or a portion their shares upon the consummation of our initial business combination, regardless of whether they vote for or against the proposed business combination or do not vote at all, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (net of taxes payable), divided by the number of the then issued and outstanding public shares, subject to the limitations described herein. The amount in the trust account is initially anticipated to be $10.00 per share, whether or not the underwriters’ over-allotment option is exercised in full. Our initial shareholders have agreed to (i) waive any right to exercise redemption rights with respect to any ordinary shares beneficially owned or to be owned by them, directly or indirectly, whether acquired before, in, or after the IPO (or to sell such shares to our company in a tender offer) and (ii) waive any and all Claims with respect to its insider shares, private shares and any Claim they may have in the future as a result of, or arising out of, any contracts or agreements with us, although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail to complete our initial business combination within the required period and to liquidating distributions from assets outside the trust account, and to not seek recourse against the trust account for any reason whatsoever. Manner of conducting redemptions At any general meeting called to approve an initial business combination, public shareholders may seek to redeem their shares, regardless of whether they vote for or against the proposed business combination or do not vote at all, into their pro rata share of the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of the initial business combination, less any taxes then due but not yet paid. Alternatively, we may provide our public shareholders who are not our sponsor, directors or officers with the opportunity to sell their ordinary shares to us through a tender offer (and thereby avoid the need for a shareholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the trust account, less any taxes then due but not yet paid. Notwithstanding the foregoing, a public shareholder, together with any affiliate of his or any other person with whom he is acting in concert or as a “group” (as defined in Section 13(d)(3) of the Exchange Act) will be restricted from seeking redemption rights in connection with any vote held to approve a proposed business combination with respect to more than 15% of the shares sold in this offering. Such a public shareholder would still be entitled to vote against a proposed business combination with respect to all shares owned by him or his affiliates. We believe this restriction will prevent shareholders from accumulating large blocks of shares before the vote held to approve a proposed business combination and attempt to use the redemption right as a means to force us or our management to purchase their shares at a significant premium to the then current market price. By limiting a shareholder’s ability to redeem no more than 15% of the shares sold in this offering, we believe we have limited the ability of a small group of shareholders to unreasonably attempt to block a transaction which is favored by our other public shareholders. Our sponsor, officers and directors will not have redemption rights with respect to any ordinary shares owned by them, directly or indirectly, whether acquired prior to this offering or purchased by them in this offering or in the aftermarket. We may require public shareholders, whether they are a record holder or hold their shares in “street name,” to either (i) tender their certificates (if any) to our transfer agent or (ii) deliver their shares to the transfer agent electronically using Depository Trust Company’s DWAC (Deposit/Withdrawal At Custodian) System, at the holder’s option, in each case prior to the date set forth in the proxy materials sent in connection with the proposal to approve the business combination, which can be up to two business days prior to the scheduled vote on the proposal to approve such business combination. There is a nominal cost associated with the above-referenced delivery process and the act of certificating the shares or delivering them through the DWAC System. The transfer agent will typically charge the tendering broker a nominal amount and it would be up to the broker whether or not to pass this cost on to the holder. However, this fee would be incurred regardless of whether or not we require holders seeking to exercise redemption rights to deliver their shares prior to a specified date. The need to deliver shares is a requirement of exercising redemption rights regardless of the timing of when such delivery must be effectuated. However, in the event we require shareholders seeking to exercise redemption rights to deliver their shares prior to the consummation of the proposed business combination and the proposed business combination is not consummated, this may result in an increased cost to shareholders. Any proxy solicitation materials we furnish to shareholders in connection with a vote for any proposed business combination will indicate whether we are requiring shareholders to satisfy such certification and delivery requirements. Accordingly, a shareholder would have from the time the shareholder received our proxy statement up until the vote on the proposal to approve the business combination to deliver his shares if he wishes to seek to exercise his redemption rights. This time period varies depending on the specific facts of each transaction. However, as the delivery process can be accomplished by the shareholder, whether or not he is a record holder or his shares are held in “street name,” in a matter of hours by simply contacting the transfer agent or his broker and requesting delivery of his shares through the DWAC System, we believe this time period is sufficient for an average investor. However, we cannot assure you of this fact. Please see the risk factor titled “In connection with any general meeting called to approve a proposed initial business combination, we may require shareholders who wish to redeem their shares in connection with a proposed business combination to comply with specific requirements for redemption that may make it more difficult for them to exercise their redemption rights prior to the deadline for exercising their rights” for further information on the risks of failing to comply with these requirements. Any request to redeem such shares, once made, may be withdrawn at any time up to the vote on the proposed business combination or the expiration of the tender offer. Furthermore, if a holder of public shares delivered its certificate in connection with an election of their redemption and subsequently decides prior to the applicable date not to elect to exercise such rights, it may simply request that the transfer agent return the certificate (physically or electronically). If the initial business combination is not approved or completed for any reason, then our public shareholders who elected to exercise their redemption rights would not be entitled to redeem their shares for the applicable pro rata share of the trust account as of two business days prior to the consummation of the initial business combination. In such case, we will promptly return any shares delivered by public holders. The following table sets forth certain information concerning our directors and executive officers as of the date of this prospectus. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%">Name</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: center">Age</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: center">Position</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Jingxia Hua</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">39</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer and Director</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Lin Sun</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">37</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Chief Financial Officer and Director</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Henrik Cronqvist</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">52</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Independent Director Nominee</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Yun Zhang</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">49</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Independent Director Nominee</td></tr> </table> Below is a summary of the business experience of each of our executive officers and directors: Ms. Jingxia Hua has served as our chief executive officer and director since November 2025. Ms. Hua has extensive experience in corporate management, technical consulting, and business development. Ms. Hua has served as Executive Director of Yaokong Technology (Shanghai) Co., Ltd. since July 2019. Since July 2019, she has overseen overall company operations at Yaokong Technology, focusing on technical consulting for new materials technology, new energy technology, and environmental protection technology, as well as technical services related to energy system integration and engineering design. From September 2018 to December 2023, Ms. Hua served as Executive Director at Senyao Energy Technology (Shanghai) Co., Ltd., where she led company operations, drove market expansion, managed cross-functional teams, and strengthened strategic partnerships and brand influence in the smart energy sector. Ms. Hua earned her International Master of Business Administration (IMBA) from Shanghai University of Finance and Economics and Webster University in 2021. We believe Ms. Hua’s extensive experience in management, technical consulting, and strategic planning qualifies her to serve on our board of directors. Ms. Lin Sun has served as our chief financial officer and director since November 2025. Ms. Sun possesses extensive experience in financial management, accounting, and corporate operations. From August 2020 to October 2024, Ms. Sun served as Assistant to the General Manager at Chengdu Weilian Totem Conference Services Co., Ltd., where she was responsible for company operations management, client marketing, and client relationship maintenance. From June 2013 to August 2020, Ms. Sun served as Financial Manager at Sichuan Dachuan High-tech Biotechnology Development Co., Ltd., where she supported the general manager in financial accounting, oversaw the company’s comprehensive accounting functions, and enhanced financial management practices through ongoing research and analysis. Ms. Sun obtained a Master’s Degree in Financial Management from Southwestern University of Finance and Economics in 2013, and a Bachelor’s Degree in Accounting from Henan University of Economics and Law in 2010. We believe Ms. Sun’s solid background in financial management, accounting, and corporate operations qualifies her to serve on our board of directors. <p id="xdx_899_espac--SpacOfficersAndDirectorsFiduciaryDutiesToOtherCompaniesDescriptionTextBlock_zQklre55xxO9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> Conflicts of Interest Under Cayman Islands law, directors owe the following fiduciary duties: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">duty to act in good faith in what the director believes to be in the best interests of the company as a whole;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">directors should not improperly fetter the exercise of future discretion;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">duty to exercise independent judgment.</td></tr> </table> <p id="xdx_89F_espac--FiduciaryDutiesToOtherCompaniesSpacOfficersAndDirectorsTableTextBlock_ztOHKPa4vPOi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%">Name of Individual</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: center">Name of Affiliated Company</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center">Industry</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%">Affiliation</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif">Jingxia Hua</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Yaokong Technology (Shanghai) Co., Ltd.</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Technical consulting and services; energy</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Director </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">Lin Sun</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">-</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">-</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">-</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">Henrik Cronqvist</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Chapman University</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Education</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">Tenured Professor</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">Yun Zhang</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">George Washington University</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">Education</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">Tenured Professor</td></tr> </table> On November 20, 2025, Spectre RH Limited agreed to pay $25,000 for the issuance of 1,725,000 insider shares (of which, 225,000 are subject to forfeiture if the underwriter does not exercise their over-allotment option), or approximately $0.014 per share. The funds were not received yet by December 31, 2025. In addition, our sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 230,000 private units for a purchase price of $10.00 per share in a private placement that will occur simultaneously with the closing of this offering (assuming the underwriter does not exercise their over-allotment option). Prior to the initial investment in the company of $25,000, the Company had no assets, tangible or intangible. The per share price of the insider shares was determined by dividing the amount paid by the number of insider shares issued in consideration therefor. If we increase or decrease the size of this offering, we will effect a share capitalization or a share surrender or redemption or other appropriate mechanism, as applicable, with respect to our insider shares immediately prior to the consummation of this offering in such amount as to maintain the ownership of our sponsor (and its permitted transferees), on an as-converted basis, at 20% of our issued and outstanding ordinary shares (excluding the private placement shares included in the private units) upon the consummation of this offering. The number of shares beneficially owned and post-offering percentages in the following table assume that the underwriter does not exercise their over-allotment option and that there are 7,730,000 ordinary shares, consisting of (i) 6,000,000 ordinary shares included in the public units sold in this offering, (ii) 1,500,000 insider shares, and (iii) 230,000 private placement shares underlying the private units purchased by our sponsor in a private placement simultaneously with the closing of this offering, issued and outstanding after this offering. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Before Offering</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">After Offering</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Name and Address of Beneficial Owner(1)</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares Beneficially Owned(2)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Approximate Percentage of Outstanding Ordinary Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares Beneficially Owned</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Approximate Percentage of Outstanding Ordinary Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Spectre RH Limited(3)(4)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">1,725,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">1,700,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">21.99</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Jingxia Hua(3)(4)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,700,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21.99</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Lin Sun</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Henrik Cronqvist(4)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">*</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Yun Zhang(4)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">*</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">All officers and directors as a group (4 persons)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,725,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,730,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22.38</td><td style="text-align: left">%</td></tr> </table> * Less than one percent. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Unless otherwise indicated, the business address of each of the individuals and entities is c/o Spectre Acquisition Corp, 1801 E Holt Blvd, #1162, Ontario, CA 91761.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Interests shown consist solely of insider shares. Such insider shares are ordinary shares with the same rights as public ordinary shares, except for certain transfer restrictions and anti-dilution provisions, as described in the section entitled “Description of Securities.”</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(3)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Spectre RH Limited, our sponsor, is the record holder of 1,725,000 insider shares, up to 225,000 such shares shall be forfeited for no consideration if the underwriters do not exercise the over-allotment option in full. Ms. Jingxia Hua is the sole member of our sponsor, and, as a result, holds voting and investment discretion with respect to the ordinary shares held of record by the sponsor.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">(4)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Our sponsor has agreed to transfer 10,000 insider shares to each of the independent director nominees immediately prior to the effectiveness of our registration statement on Form S-1, of which this prospectus is a part.</td></tr> </table> <p id="xdx_899_espac--SpacSponsorAndAffiliatesInformationRestrictionsOnSaleOfSpacSecuritiesTableTextBlock_dU_zgu51hQMHjNi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center">SUBJECT SECURITIES</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 39%; text-align: center">TRANSFER RESTRICTIONS</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%">NATURAL PERSONS AND ENTITIES SUBJECT TO TRANSFER RESTRICTIONS</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: center">EXCEPTIONS TO TRANSFER RESTRICTIONS</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Insider Shares(1)(2)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_902_espac--SpacSponsorDescriptionOfExpirationDatesOfRestrictionsTextBlock_c20260331__20260331__spac--SecurityClassAxis__custom--InsiderSharesMember_fKDEpKDIp_zX9sNyxVtIAk">Agreement not to (a) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, or establish or increase a put equivalent position or liquidation with respect to or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act and the rules and regulations of the SEC promulgated thereunder with respect to, any security, (b) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) publicly announce any intention to effect any transaction specified in clause (a) or (b) (each of the foregoing, a “Transfer”), until the earlier of (i) six months after the completion of an initial business combination and (ii) subsequent to our initial business combination, (A) if the last reported sale price of our ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing any time 150 days after completion of our initial business combination or (B) the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Further, no Transfer of any ordinary shares, insider shares or any other securities convertible into, or exercisable or exchangeable for, ordinary shares until 180 days after the date of this prospectus.</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_909_espac--SpacSponsorPersonsAndEntitiesSubjectToRestrictions_c20260331__20260331__spac--SecurityClassAxis__custom--InsiderSharesMember_fKDEpKDIp_zXI6rj3AqVu9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Spectre RH Limited, Jingxia Hua, Lin Sun, Henrik Cronqvist and Yun Zhang.</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_90B_espac--SpacSponsorDescriptionOfExceptionsToRestrictionsTextBlock_c20260331__20260331__spac--SecurityClassAxis__custom--InsiderSharesMember_fKDEpKDIp_zNoimqVkbmk4">Exceptions include: (i) among the initial shareholders or to an initial shareholder’s member, partner, officer, director, or affiliate; (ii) by gift to a member of the initial shareholder’s immediate family or to a trust, the beneficiary of which is a member of the initial shareholder’s immediate family or an affiliate of such individual, or to a charitable organization; (iii) by virtue of laws of descent and distribution upon death; (iv) pursuant to a qualified domestic relations order; (v) by virtue of the sponsor’s organizational documents upon liquidation or dissolution of the sponsor; or (vi) in the event of our liquidation prior to the completion of an initial business combination; provided, however, that, in the case of clauses (i) through (v), each transferee agrees in writing to be bound by the Transfer restrictions and the other restrictions contained in the letter agreement.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Private units and underlying securities(1)(2)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_90F_espac--SpacSponsorDescriptionOfExpirationDatesOfRestrictionsTextBlock_c20260331__20260331__spac--SecurityClassAxis__custom--PrivateUnitsMember_fKDEpKDIp_zBQ2IohF5ije">No Transfer until 30 days after the completion of our initial business combination. Further, no Transfer of any ordinary shares, insider shares or any other securities convertible into, or exercisable or exchangeable for, ordinary shares until 180 days after the date of this prospectus.</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_90A_espac--SpacSponsorPersonsAndEntitiesSubjectToRestrictions_c20260331__20260331__spac--SecurityClassAxis__custom--PrivateUnitsMember_fKDEpKDIp_za35cS8bsDD2">Spectre RH Limited </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_909_espac--SpacSponsorDescriptionOfExceptionsToRestrictionsTextBlock_c20260331__20260331__spac--SecurityClassAxis__custom--PrivateUnitsMember_fKDEpKDIp_zi7ziYs5R3Ic">Same as above.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">Public Units and underlying securities (if any are purchased in connection with the offering)(2)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_906_espac--SpacSponsorDescriptionOfExpirationDatesOfRestrictionsTextBlock_c20260331__20260331__spac--SecurityClassAxis__spac--PublicUnitsMember_fKDIp_zcfJDDSvNcvf">No Transfer of any ordinary shares, insider shares or any other securities convertible into, or exercisable or exchangeable for, ordinary shares until 180 days after the date of this prospectus.</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_907_espac--SpacSponsorPersonsAndEntitiesSubjectToRestrictions_c20260331__20260331__spac--SecurityClassAxis__spac--PublicUnitsMember_fKDIp_zvQhfVPs2ha4">Spectre RH Limited, Jingxia Hua, and Lin Sun</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_909_espac--SpacSponsorDescriptionOfExceptionsToRestrictionsTextBlock_c20260331__20260331__spac--SecurityClassAxis__spac--PublicUnitsMember_fKDIp_zNRjK5nr8fub">Same as above.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">For more information on the number of securities beneficially held by our sponsor, please see the section entitled “Principal Shareholders” in this prospectus.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The insider shares and private units, including any private placement shares and private warrants included in such private units, issued in connection or simultaneously with this offering are restricted securities and subject to the limitations on transfer described above under “—Rule 144” and “—Restrictions on the Use of Rule 144 by Shell Companies or Former Shell Companies.” Further, our sponsor, its permitted transferees or any other person that becomes an affiliate of the post-business combination company for purposes of Rule 144 under the Securities Act may be subject to additional resale restrictions with respect to securities they hold, as described above.</td></tr> </table> Agreement not to (a) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, or establish or increase a put equivalent position or liquidation with respect to or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act and the rules and regulations of the SEC promulgated thereunder with respect to, any security, (b) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) publicly announce any intention to effect any transaction specified in clause (a) or (b) (each of the foregoing, a “Transfer”), until the earlier of (i) six months after the completion of an initial business combination and (ii) subsequent to our initial business combination, (A) if the last reported sale price of our ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and other similar transactions) for any 20 trading days within any 30-trading day period commencing any time 150 days after completion of our initial business combination or (B) the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Further, no Transfer of any ordinary shares, insider shares or any other securities convertible into, or exercisable or exchangeable for, ordinary shares until 180 days after the date of this prospectus. Spectre RH Limited, Jingxia Hua, Lin Sun, Henrik Cronqvist and Yun Zhang. Exceptions include: (i) among the initial shareholders or to an initial shareholder’s member, partner, officer, director, or affiliate; (ii) by gift to a member of the initial shareholder’s immediate family or to a trust, the beneficiary of which is a member of the initial shareholder’s immediate family or an affiliate of such individual, or to a charitable organization; (iii) by virtue of laws of descent and distribution upon death; (iv) pursuant to a qualified domestic relations order; (v) by virtue of the sponsor’s organizational documents upon liquidation or dissolution of the sponsor; or (vi) in the event of our liquidation prior to the completion of an initial business combination; provided, however, that, in the case of clauses (i) through (v), each transferee agrees in writing to be bound by the Transfer restrictions and the other restrictions contained in the letter agreement. No Transfer until 30 days after the completion of our initial business combination. Further, no Transfer of any ordinary shares, insider shares or any other securities convertible into, or exercisable or exchangeable for, ordinary shares until 180 days after the date of this prospectus. Spectre RH Limited Same as above. No Transfer of any ordinary shares, insider shares or any other securities convertible into, or exercisable or exchangeable for, ordinary shares until 180 days after the date of this prospectus. Spectre RH Limited, Jingxia Hua, and Lin Sun Same as above. In order to facilitate our initial business combination or for any other reason determined by our sponsor, our sponsor may, with our consent, (i) surrender or forfeit, transfer or exchange our insider shares, private units or any of our other securities, including for no consideration in connection with a PIPE financing or otherwise, (ii) subject any such securities to earn-outs or other restrictions, held by it and (iii) enter into any other arrangements with respect to any such securities. See following table for numerator of the pro forma net tangible book value divided by denominator of the shares outstanding. We assume the net tangible book value before this offering will be increased by net proceeds from this offering and offering costs accrued in advance but further set off by deferred underwriting commissions and proceeds held in trust subject to redemption. See following table for numerator of the pro forma net tangible book value divided by denominator of the shares outstanding. We assume the net tangible book value before this offering will be increased by net proceeds from this offering and offering costs accrued in advance but further set off by deferred underwriting commissions and proceeds held in trust subject to redemption. The numbers set forth in this column assume that 1,725,000 public shares, or 25% of 6,900,000 public shares, are redeemed. The numbers set forth in this column assume that 3,450,000 public shares, or 50% of 6,900,000 public shares, are redeemed. The numbers set forth in this column assume that 5,175,000 public shares, or 75% of 6,900,000 public shares, are redeemed. The numbers set forth in this column assume that 6,900,000 public shares or 100% of 6,900,000 public shares are redeemed. The numbers set forth in this column assume that 1,500,000 public shares, or 25% of 6,000,000 public shares, are redeemed. The numbers set forth in this row assume that $60,000,000 will be held in the trust account (or $69,000,000 if the underwriter’s over-allotment option is fully exercised) plus $800,000 in working capital held outside the trust account immediately after the offering. See “Use of Proceeds.” If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our sponsor, directors, executive officers, advisors or any of their affiliates may purchase public shares or public units in privately negotiated transactions or in the open market either prior to or following the completion of our initial business combination. In the event of any such purchases of our shares prior to the completion of our initial business combination, the number of ordinary shares subject to redemption will be reduced by the amount of any such purchases, increasing the pro forma net tangible book value per share. See “Proposed Business — Effecting Our Initial Business Combination — Permitted purchases of our securities by our affiliates.” The numbers set forth in this column assume that 3,000,000 public shares, or 50% of 6,000,000 public shares, are redeemed. The numbers set forth in this column assume that 4,500,000 public shares, or 75% of 6,000,000 public shares, are redeemed. The numbers set forth in this column assume that 6,000,000 public shares, or 100% of 6,000,000 public shares are redeemed. For more information on the number of securities beneficially held by our sponsor, please see the section entitled “Principal Shareholders” in this prospectus. The insider shares and private units, including any private placement shares and private warrants included in such private units, issued in connection or simultaneously with this offering are restricted securities and subject to the limitations on transfer described above under “—Rule 144” and “—Restrictions on the Use of Rule 144 by Shell Companies or Former Shell Companies.” Further, our sponsor, its permitted transferees or any other person that becomes an affiliate of the post-business combination company for purposes of Rule 144 under the Securities Act may be subject to additional resale restrictions with respect to securities they hold, as described above.